After evaluating immunostained paired tumour and peritumoural specimens from 75 glioma patients and normal brain specimens from 5 epilepsy patients, we observed a relatively low level of TMEFF2 protein expression in 70.67 % (53/75) of all tumour specimens. This evidence concerns the gene TMEFF2 and central nervous system cancer.